Selective potentiation of sympathomimetic amines by reserpine. syrosingopine and 2,6-xylylcholine ether bromide (TM-10) in the dog.
D000818:Animals; D001949:Bretylium Compounds; D001965:Bromides; D002794:Choline; D003042:Cocaine; D004295:Dihydroxyphenylalanine; D004285:Dogs; D004298:Dopamine; D004986:Ether; D006145:Guanethidine; D007490:Iproniazid; D009638:Norepinephrine; D010627:Phenethylamines; D010659:Phenylhydrazines; D012110:Reserpine / Q000031:analogs & derivatives; D013566:Sympathomimetics; D014439:Tyramine
D001949:Bretylium Compounds; D001965:Bromides; D010627:Phenethylamines; D010659:Phenylhydrazines; D013566:Sympathomimetics; C030299:phenylhydrazine; D004986:Ether; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D007490:Iproniazid; D003042:Cocaine; D002794:Choline; C084824:syrosingopine; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine; D006145:Guanethidine
BRETYLIUM COMPOUNDS; CHOLINE; COCAINE; DOPA; DOPAMINE; GUANETHIDINE; IPRONIAZID; NOREPINEPHRINE; PHENYLETHYLAMINES; PHENYLHYDRAZINE; RESERPINE; SYROSINGOPINE; TYRAMINE